Patents Assigned to Applied Analytical Industries, Inc.
-
Patent number: 5976570Abstract: A process for making pharmaceutical dosage units containing a therapeutic quantity of one or more low dosage medicinal agent comprising granulating said medicinal agent in an aqueous medium which contains a pharmaceutically acceptable surfactant agent and, optionally, further processing the product of said granulating into a tablet or capsule dosage unit.Type: GrantFiled: July 15, 1996Date of Patent: November 2, 1999Assignee: Applied Analytical Industries, Inc.Inventors: Frank C. Greaves, James Swarbrick, Martin W. Beasley, Andrew W. Suddith, Henry C. Caldwell
-
Patent number: 5928668Abstract: Disclosed is a method of dry blend compression of potent drugs with low solubility, such as steroidal medicaments using directly compressible agglomerated excipients that are not a conventional or spray dried polyalcohol or lactose. The agglomerated excipients include mannitol, maltodextrin or corn syrup solids, which hold the medicament(s) in the crevices of the agglomerates. Also disclosed are the critical ratios of the agglomerated excipients to steroidal agent, specifically estradiol, that is distributed uniformly throughout the dry blend and then compressed into tablets.Type: GrantFiled: August 1, 1996Date of Patent: July 27, 1999Assignee: Applied Analytical Industries, Inc.Inventors: Frank C. Greaves, James Swarbrick, Martin W. Beasley
-
Patent number: 5902844Abstract: Methods of forming solid pharmaceutical compositions comprise solubilizing water-soluble polymers and amino acid-based components having molecular weights ranging from about 100 daltons to about 200,000 daltons or pharmaceutically acceptable salts thereof in solvents; and separating the solvents from the water-soluble polymers and the amino acid-based components or pharmaceutically acceptable salts thereof to form solid pharmaceutical compositions comprising the water-soluble polymers and the amino acid-based components or pharmaceutically acceptable salts thereof.Type: GrantFiled: February 2, 1998Date of Patent: May 11, 1999Assignee: Applied Analytical Industries, Inc.Inventor: Edward S. Wilson
-
Patent number: 5622980Abstract: The present invention provides a pharmaceutical composition for the oral administration of an H.sub.2 -antagonist. The composition includes an H.sub.2 -antagonist and a silicate taste-masking agent capable of forming an adsorbate complex with the H.sub.2 -antagonist wherein the complex exhibits a non-bitter taste. The complex inhibits the release of the H.sub.2 -antagonist in the oral cavity.Type: GrantFiled: February 2, 1995Date of Patent: April 22, 1997Assignee: Applied Analytical Industries, Inc.Inventors: Henry C. Caldwell, Ashok J. Desai
-
Patent number: 5538737Abstract: The present invention provides pharmaceutical capsule compositions for the oral administration of an H.sub.2 -antagonist. The composition includes a capsule containing an emulsion having a water portion and an oil portion. A pharmaceutically acceptable salt of an H.sub.2 -antagonist is dissolved in the water portion. The composition delivers a therapeutically effective amount of the H.sub.2 -antagonist to a patient in need thereof. The present invention also provides methods of making the capsule composition.Type: GrantFiled: November 30, 1994Date of Patent: July 23, 1996Assignee: Applied Analytical Industries, Inc.Inventors: Thomas W. Leonard, David P. Hause, Frederick D. Sancilio, James Swarbrick, Edward S. Wilson
-
Patent number: 5206219Abstract: Proteinaceous medicaments such as erythropoetin, insulin and calcitonin are formulated in a medium comprising a polyol pharmaceutical solvent combined as co-solvent with a lipid pharmaceutical solvent. The formulation is adapted for oral administration as a liquid as well as a filled hard or soft gelatin capsule. The preferred polyol solvent is polyethylene glycol/propylene glycol; the preferred lipid solvent is oleic acid.Type: GrantFiled: November 25, 1991Date of Patent: April 27, 1993Assignee: Applied Analytical Industries, Inc.Inventor: Ashok J. Desai
-
Patent number: 5183829Abstract: Pharmaceutically elegant oral compositions of non-steroidal anti-inflammatory drugs or their salts are prepared by adding selected dispersing agents such as a polyvinylpyrrolidone, hydroxypropyl-methylcellulose or hydroxypropylcellulose to the NSAIDs in a medium of polyol-glycol-alcohol. The compositions offer the formation of finely dispersed active ingredients upon dispersion in gastric juice.Type: GrantFiled: September 27, 1991Date of Patent: February 2, 1993Assignee: Applied Analytical Industries, Inc.Inventor: Henry C. Caldwell
-
Patent number: 5084446Abstract: A sucralfate-like chemical compound which is free flowing but turns viscid upon contact with acid or non-acid aqueous liquid. The compound is prepared by adding an excess of aluminum chlorohydrate to sucrose octaammonium sulfate in aqueous alcohols.Type: GrantFiled: July 19, 1989Date of Patent: January 28, 1992Assignee: Applied Analytical Industries, Inc.Inventors: John M. Baldoni, Nick V. Lazaridis
-
Patent number: 5059626Abstract: A one phase, liquid composition for oral administration comprises a NSAID such as an anthranilic acid derivative plus a di- or triglyceride of a medium chain fatty acid edible oil which has the characteristics of a pharmaceutical solvent carrier as known to those skilled in the art. Other pharmaceutical additives may be optionally added. An additional stipulation is that ethanol or other monohydric alcohol solvents should not be present.Type: GrantFiled: January 30, 1991Date of Patent: October 22, 1991Assignee: Applied Analytical Industries, Inc.Inventors: Moo W. Park, Henry C. Caldwell
-
Patent number: 5011852Abstract: A one phase, liquid composition for oral administration comprises a NSAID such as an indoleacetic acid derivative or a pyrroleacetic acid derivative plus a di- or triglyceride of a medium chain fatty acid edible oil which has the characteristics of a pharmaceutical solvent carrier as known to those skilled in the art. Other pharmaceutical additives may be optionally added. An additional stipulation is that ethanol or other monohydric alcohol solvents should not be present.Type: GrantFiled: March 6, 1990Date of Patent: April 30, 1991Assignee: Applied Analytical Industries, Inc.Inventors: Moo K. Park, Henry C. Caldwell
-
Patent number: 4990610Abstract: Sucralfate is prepared in good yields and in newly useful form first by reacting sucrose with chlorosulfonic acid in 2-picoline. The amonium salt is then formed and reacted with aluminum chlorohydrate in specific sequence and alcoholic solvent. The two distinct products have unexpected pharmaceutical and physical characteristics. The oral liquid suspensions also must be critically formulated.Type: GrantFiled: December 16, 1988Date of Patent: February 5, 1991Assignee: Applied Analytical Industries, Inc.Inventors: Nick V. Lazaridis, Moo K. Park, Yousry Sayed